31/01/2026
Bryan Johnson has undertaken an experiment that stands out even by his own unconventional standards: he consumed 5 grams of psilocybin mushrooms while monitoring his brain activity in real time using advanced imaging technology. His goal was to determine whether the mental shifts produced by psychedelics could have relevance for longevity—similar to the focus placed on telomeres, senescent cells, and other biological aging markers. Once the psilocybin took effect, his brain activity changed sharply. The prefrontal cortex, responsible for planning, discipline, and self-control, became significantly less active, while sensory and motor regions became highly engaged. His internal monologue quieted. His subjective experience closely aligned with these patterns. He reported an intense level of consciousness, an unusual fascination with simple stimuli like light in a jar, and dramatically heightened tactile and taste perception. These effects match what science already understands about psilocybin. After ingestion, psilocybin converts into psilocin, which stimulates 5-HT₂A receptors in the cortex. Activation of these receptors disrupts the brain’s usual top-down control system and increases flexibility, connectivity, and overall neural entropy—making the brain operate in a more exploratory, childlike state. Johnson’s scans closely reflected the known distribution of these receptors, reinforcing the consistency of the findings. At the height of the experience, his brain was dominated by sensory processing. The prefrontal cortex remained subdued, allowing unfiltered sensory input to become vivid and emotionally charged. Although he did not reach full ego dissolution—typically associated with higher doses—he clearly entered a state that broke his usual cognitive patterns. As the effects tapered, his brain gradually returned to baseline. The prefrontal cortex regained activity, and the Default Mode Network re-emerged. Internally, he shifted from pure sensory immersion to broader contemplation about mortality, humanity, and meaning. The next morning, the “afterglow” remained visible in both his behavior and his brain scans. His sensory acuity was heightened, speech and creativity networks were still more active than usual, and his Default Mode Network was only partially restored. Emotionally, he felt clearer, lighter, more humorous, and energized—a well-documented post-psychedelic effect, now visually confirmed by imaging. Johnson is particularly interested in the implications for longevity. Research already shows that emotional well-being, optimism, and purpose correlate with lower mortality. Early studies also suggest psychedelics may influence biological aging markers and enhance cellular resilience. He argues that aging is not solely a biological process; it is also cognitive. As people grow older, their mental patterns often become rigid and predictable. Psychedelics might temporarily loosen those patterns, supporting a form of “mental youthfulness” that could influence physical health. Johnson plans to continue measuring his brain daily to track how long these changes persist. Whether psychedelics ultimately become validated tools in longevity science remains to be seen, but this experiment demonstrates something significant: his subjective experience and objective brain data aligned almost perfectly. He felt more open, engaged, and alive—and his brain objectively displayed those shifts. Independent of the longevity discussion, the work provides a rare, detailed view of how consciousness reorganizes when the habitual filters of adulthood loosen. It is a striking and thought-provoking snapshot of the mind under transformation.
